Neil Kumar's BridgeBio finds 7 new academic partners to join the fight against genetic disease
April 13, 2021
While describing OHSU’s collaboration with BridgeBio Pharma, Inc., to research and develop investigational medicines for patients with genetically driven conditions, Peter Barr-Gillespie, Ph.D., says: “We see this collaboration as an important part of our efforts to bring OHSU innovations to clinical significance.”